## IEX: IDEX Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.6% below STRENGTH zone (3.0-6.0%); PEG 1.71 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($177.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. IDEX Corporation‘s Q4 2025 Earnings: What to Expect**
- Source: inkl | 20260106T080822 | Somewhat-Bullish | Relevance: 100%
- IDEX Corporation (IEX) is preparing to release its fiscal Q4 2025 earnings on February 3rd, with Wall Street anticipating diluted EPS of $2.04, flat year-over-year. Despite the company consistently surpassing EPS estimates in recent quarters and maintaining a "Moderate Buy" rating from analysts with an implied upside of 6.3%, its stock performance has lagged broader benchmarks and the industrial sector over the past year.

**2. IDEX Corporation’s Fourth Quarter 2025 Earnings: Anticipated Highlights**
- Source: Bitget | 20260105T200812 | Somewhat-Bullish | Relevance: 100%
- IDEX Corporation (IEX) is preparing to release its Q4 2025 earnings report on February 3, 2026, with analysts expecting diluted EPS of $2.04—matching the prior year. Despite recent stock underperformance, IDEX has consistently surpassed EPS forecasts and saw a surge after its strong Q3 2025 results, driven by growth in Health & Science Technologies. The company maintains a "Moderate Buy" consensus from analysts, who project an average price target of $192.27.

**3. Harvey Investment Co. LLC Acquires 21,608 Shares of IDEX Corporation $IEX**
- Source: MarketBeat | 20260105T132923 | Bullish | Relevance: 100%
- Harvey Investment Co. LLC increased its stake in IDEX Corporation by 24.6% in Q3, purchasing an additional 21,608 shares to hold a total of 109,344 shares valued at approximately $17.8 million. IDEX also announced a $1.0 billion share repurchase program and a quarterly dividend of $0.71 per share. Analysts have a "Moderate Buy" rating on IDEX with a consensus price target of $196.86.

**4. IDEX Corporation (NYSE:IEX) Given Average Rating of "Moderate Buy" by Analysts**
- Source: MarketBeat | 20260104T084304 | Bullish | Relevance: 100%
- IDEX Corporation (NYSE:IEX) has received a "Moderate Buy" consensus rating from seven analysts, with an average 12-month price target of $196.86. The company recently reported EPS of $1.79 on $712 million revenue for its last quarter and announced a $1.00 billion share buyback program and a $0.71 quarterly dividend. Institutional investors hold 97.96% of the company's stock, which recently opened at $179.02.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $202 | $197 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.10M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (-1.1%)
- Wellington Managemen: 8.6% (+3.4%)
- Blackrock Inc.: 7.6% (-1.8%)
- Morgan Stanley: 4.5% (+7.6%)
- State Street Corpora: 4.2% (+1.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +1.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.71 elevated, pricing in significant growth expectations. Forward P/E 22.1x stretched relative to 5% growth. Balance sheet: strong liquidity (2.9x). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.8B |
| Beta | 0.99 |
| 52W Range | $153.36 - $226.05 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.71 |
| Forward P/E | 22.1 |
| Current P/E | 23.3 |
| YoY Growth | 5.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.2% to 1.6% (+1.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.4pp (needs >3.0% for momentum thesis). MRS_5 at 1.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.60% (CS: 55) | Neutral |
| RSI_14 | 67.4 | Neutral |
| MACD Histogram | -0.03 | Bearish |
| vs SMA20 | 1.028x | Above |
| vs SMA50 | 1.060x | Above |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $183.76
- **Stop Loss:** $177.60 (3.4% risk)
- **Target:** $189.92 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 214
- **Position Value:** $39,324.64
- **Portfolio %:** 39.32%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-03 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.93 | $2.03 | +5.2% |
| 2025Q2 | $1.99 | $2.07 | +4.0% |
| 2025Q1 | $1.64 | $1.75 | +6.7% |
| 2024Q4 | $2.03 | $2.04 | +0.5% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*